Danaher Q3 Earnings Surpass Estimates, Diagnostics Sales Up Y/Y

Danaher Corporation’s (DHR) third-quarter 2024 adjusted earnings (excluding 59 cents from non-recurring items) of $1.71 per share surpassed the Zacks Consensus Estimate of $1.56. The bottom line declined 0.6% year over year.Danaher’s reported net sales of $5.8 billion, which beat the consensus estimate of $5.6 billion. The metric increased 3.1% year over year, driven by robust sales in the Diagnostics and Life Sciences segments.DHR’s core sales increased 0.5%. Acquisitions had a positive impact of 2.5% on q ...